Mr. Speaker, let me reassure the hon. member that at this point no final decision has been made in relation to any of the labs we operate across Canada.
I think the hon. member is probably aware that we have had an expert, Dr. J. Mayer, review the operation of our DAS system and we are reviewing his recommendations. Our goal is to ensure the highest quality and most efficient drug analysis service to Canadians.